170 related articles for article (PubMed ID: 2346907)
1. Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy.
Conlon KC; Urba WJ; Smith JW; Steis RG; Longo DL; Clark JW
Cancer; 1990 May; 65(10):2237-42. PubMed ID: 2346907
[TBL] [Abstract][Full Text] [Related]
2. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors.
Rönnblom LE; Alm GV; Oberg KE
Ann Intern Med; 1991 Aug; 115(3):178-83. PubMed ID: 2058872
[TBL] [Abstract][Full Text] [Related]
3. Immune-mediated complications during interferon therapy in hematological patients.
Raanani P; Ben-Bassat I
Acta Haematol; 2002; 107(3):133-44. PubMed ID: 11978934
[TBL] [Abstract][Full Text] [Related]
4. Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1 interferons for HCV-related chronic hepatitis: a prospective study.
Mazziotti G; Sorvillo F; Stornaiuolo G; Rotondi M; Morisco F; Ruberto M; Cioffi M; Amato G; Caporaso N; Gaeta GB; Carella C
J Endocrinol Invest; 2002; 25(7):624-30. PubMed ID: 12150338
[TBL] [Abstract][Full Text] [Related]
5. Transient Hypothyroidism and Autoimmune Thyroiditis in Children With Chronic Hepatitis C Treated With Pegylated-interferon-α-2b and Ribavirin.
Serranti D; Indolfi G; Nebbia G; Cananzi M; D'Antiga L; Ricci S; Stagi S; Azzari C; Resti M;
Pediatr Infect Dis J; 2018 Apr; 37(4):287-291. PubMed ID: 28953189
[TBL] [Abstract][Full Text] [Related]
6. Development of transient autoimmune hepatitis during interferon treatment of chronic hepatitis B.
Cianciara J; Laskus T
Dig Dis Sci; 1995 Aug; 40(8):1842-4. PubMed ID: 7648989
[TBL] [Abstract][Full Text] [Related]
7. Exacerbation of ulcerative colitis during alpha-interferon therapy for chronic hepatitis C.
Mitoro A; Yoshikawa M; Yamamoto K; Mimura M; Yoshikawa Y; Shiroi A; Mochi T; Sakamoto T; Yamao J; Kikuchi E
Intern Med; 1993 Apr; 32(4):327-31. PubMed ID: 8102914
[TBL] [Abstract][Full Text] [Related]
8. Interferon-alpha and autoimmune thyroid disease.
Prummel MF; Laurberg P
Thyroid; 2003 Jun; 13(6):547-51. PubMed ID: 12930598
[TBL] [Abstract][Full Text] [Related]
9. Interferon-alpha-induced hyperthyroidism: a three-stage evolution from silent thyroiditis towards Graves' disease.
Bohbot NL; Young J; Orgiazzi J; Buffet C; François M; Bernard-Chabert B; Lukas-Croisier C; Delemer B
Eur J Endocrinol; 2006 Mar; 154(3):367-72. PubMed ID: 16498048
[TBL] [Abstract][Full Text] [Related]
10. Exacerbation of thyroid autoimmunity by interferon alpha treatment in patients with chronic viral hepatitis: our studies and review of the literature.
Nagayama Y; Ohta K; Tsuruta M; Takeshita A; Kimura H; Hamasaki K; Ashizawa K; Nakata K; Yokoyama N; Nagataki S
Endocr J; 1994 Oct; 41(5):565-72. PubMed ID: 7889118
[TBL] [Abstract][Full Text] [Related]
11. The influence of interferon alpha on the induction of autoimmune thyroiditis in patients treated for chronic viral hepatitis type C.
Krupińska J; Wawrzynowicz-Syczewska M; Urbanowicz W; Pobłocki J; Syrenicz A
Endokrynol Pol; 2011; 62(6):517-22. PubMed ID: 22144218
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune endocrine disease induced by recombinant interferon-alpha therapy for chronic active type C hepatitis.
Imagawa A; Itoh N; Hanafusa T; Oda Y; Waguri M; Miyagawa J; Kono N; Kuwajima M; Matsuzawa Y
J Clin Endocrinol Metab; 1995 Mar; 80(3):922-6. PubMed ID: 7883851
[TBL] [Abstract][Full Text] [Related]
13. Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis.
Chung YH; Shong YK
Am J Gastroenterol; 1993 Feb; 88(2):244-7. PubMed ID: 8424429
[TBL] [Abstract][Full Text] [Related]
14. [Interferon alpha antibodies show no cross reactions with typical autoantibodies].
Görg S; Klouche M; Wilhelm D; Kirchner H
Immun Infekt; 1993 Apr; 21 Suppl 1():54-6. PubMed ID: 8344695
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune mediated thrombocytopenia associated with the use of interferon-alpha in chronic myeloid leukemia.
Zuffa E; Vianelli N; Martinelli G; Tazzari P; Cavo M; Tura S
Haematologica; 1996; 81(6):533-5. PubMed ID: 9009441
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune phenomena in patients with malignant carcinoid tumors during interferon-alpha treatment.
Rönnblom LE; Alm GV; Oberg K
Acta Oncol; 1991; 30(4):537-40. PubMed ID: 1854511
[TBL] [Abstract][Full Text] [Related]
17. Dual onset of type 1 diabetes mellitus and Graves' disease during treatment with pegylated interferon alpha-2b and ribavirin for chronic hepatitis C.
Hayashi M; Kataoka Y; Tachikawa K; Koguchi H; Tanaka H
Diabetes Res Clin Pract; 2009 Nov; 86(2):e19-21. PubMed ID: 19744739
[TBL] [Abstract][Full Text] [Related]
18. Clinical Value of Thyrotropin Receptor Antibodies for the Differential Diagnosis of Interferon Induced Thyroiditis.
Benaiges D; Garcia-Retortillo M; Mas A; Cañete N; Broquetas T; Puigvehi M; Chillarón JJ; Flores-Le Roux JA; Sagarra E; Cabrero B; Zaffalon D; Solà R; Pedro-Botet J; Carrión JA
Exp Clin Endocrinol Diabetes; 2016 Jan; 124(1):39-44. PubMed ID: 26575116
[TBL] [Abstract][Full Text] [Related]
19. Two cases of hypothyroidism associated with alpha-interferon therapy.
Taniguchi Y; Murakami T; Nakanishi K; Tamai M; Matsuura B; Masumoto T; Onji M; Tajiri J; Noguchi S; Ohta Y
Intern Med; 1992 Mar; 31(3):373-6. PubMed ID: 1611189
[TBL] [Abstract][Full Text] [Related]
20. Hypothyroidism and arthritis during interferon therapy.
D'Hondt L; Delannoy A; Docquier C
Clin Rheumatol; 1993 Sep; 12(3):415-7. PubMed ID: 7504985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
